Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
They forgot the word “indefinitely”
There’s a bit of “unexpected” news. In the body of this seemingly good news release BKYI discloses that their Africa deal will be delayed. Now which long term shareholder didn’t see that coming?
Global Railcar Leasing Leader GATX Corporation Expands Use of BIO-key's PortalGuard Solution to Enable Secure and Flexible Password Management for its Largely Remote-Work European Operations Team
WALL, N.J., Dec. 14, 2020 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of identity and access management (IAM) solutions powered by biometrics, today announced that GATX Corporation, the leading global railcar leasing company, has chosen to expand their use of BIO-key's PortalGuard IAM solution to its GATX Rail Europe operations to deliver cost-effective and secure password management to improve their employees' end-user experience and reduce related costs.
Due to the COVID-19 pandemic, GATX Rail Europe's operations team has shifted most of their employees to remote work, creating the need to implement secure password management from remote locations. The IT team was faced with runaway Help Desk costs supporting employees in the work-from-home model while it strove to deliver a great user experience. The PortalGuard IAM solution met important project goals that included cybersecurity, reduced IT resource costs, and the enforcement and management of strong passwords on all devices, whether company-owned or not.
"Since 2004, our team has built a strong track record delivering multiple value-add security solutions to GATX," said Mark Cochran, President of BIO-key - PortalGuard. "Events this year have substantially accelerated enterprise adoption of the work-from-home model, resulting in widespread security and identity challenges, rising costs, and workflow disruption. PortalGuard is an ideal solution for these challenges, providing the perfect balance of security, usability, and rapid deployment, all at a very competitive cost. Expanding our footprint within an existing customer is both gratifying and the strongest possible endorsement of the value and flexibility of our PortalGuard solution."
About BIO-key International, Inc. (www.bio-key.com)
BIO-key is revolutionizing authentication with biometric centric, multi-factor identity and access management (IAM) solutions, including its PortalGuard IAM solution, that provide convenient and secure access to devices, information, applications, and high-value transactions. BIO-key's proprietary software and hardware solutions, with industry-leading biometric capabilities, enable large-scale on-premise and Identity-as-a-Service (IDaaS) solutions, including customized enterprise and cloud solutions.
BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes," and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; our ability to execute and deliver on contracts in Africa; our ability to expand into Asia, Africa and other foreign markets; the duration and severity of the current coronavirus COVID-19 pandemic and its effect on our business operations, sales cycles, 3 personnel, and the geographic markets in which we operate; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption see "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2019 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, the Company undertakes no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise. Additionally, there may be other factors of which the Company is not currently aware that may affect matters discussed in forward-looking statements and may also cause actual results to differ materially from those discussed. In particular, the consequences of the coronavirus outbreak to economic conditions and the industry in general and the financial position and operating results of our Company, in particular, have been material, are changing rapidly, and cannot be predicted.
Engage with BIO-key
Facebook – Corporate: https://www.facebook.com/BIOkeyInternational/
LinkedIn – Corporate: https://www.linkedin.com/company/bio-key-international
Twitter – Corporate: @BIOkeyIntl
Twitter – Investors: @BIO_keyIR
StockTwits: BIO_keyIR
Investor & Media Contacts
William Jones & David Collins
Catalyst IR 212-924-9800
bkyi@catalyst-ir.com
Identity and Access Management Provider BIO-key Presents at LD Micro Virtual Main Event 2020 Conference, Tuesday December 15th at 3:20pm ET
WALL, N.J., Dec. 09, 2020 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of identity and access management (IAM) solutions powered by biometrics will present at the LD Micro Virtual Main Event 2020 Investor Conference on Tuesday, December 15th. BIO-key’s Chairman and CEO Mike DePasquale will give an introduction and address questions from an investor panel, beginning at 3:20pm ET and ending at 3:40pm ET.
The LD Micro Virtual Main Event conference takes place December 14th and 15th and will feature over 200 small / micro-cap companies.
To learn more or to register for the Main Event please visit: https://ve.mysequire.com/
Chris Lahiji, Founder of LD, commented, “This year’s Main Event features a unique format that will make it the first virtual conference this year that is engaging instead of repetitive. There have been too many 20-minute PowerPoints, and investors have lost the desire to watch one more of the same thing. We intend to showcase great companies in a much more engaging format.”
View BIO-key’s LD Micro profile here: http://www.ldmicro.com/profile/BKYI
About LD Micro
LD Micro is a leading independent information resource and investment community event platform providing valuable tools for everyone in the small and micro-cap investment universe. The LD Micro Index (the LDMi), the first pure microcap index, was launched in 2015 to provide a useful benchmark and flow of information to support participants in the micro-cap sector. Please contact David Scher at david@ldmicro.com or visit www.ldmicro.com for more information.
About BIO-key International, Inc. (www.bio-key.com)
BIO-key is revolutionizing authentication with biometric centric, multi-factor identity and access management (IAM) solutions, including its PortalGuard IAM solution, that provide convenient and secure access to devices, information, applications and high-value transactions. BIO-key’s proprietary software and hardware solutions, with industry leading biometric capabilities, enable large-scale on-premise and Identity-as-a-Service (IDaaS) solutions as well as customized enterprise and cloud solutions.
Engage with BIO-key
Twitter:
StockTwits:
@BIO_keyIR
BIO_keyIR
Investor & Media Contacts
William Jones, David Collins
Catalyst IR
212-924-9800
bkyi@catalyst-ir.com
We will see!!
Reuters..
BKYI one year earnings forecast...
998,924.4 % increase
ITS ABOUT TIME.....
BIO-key email received:
“Secure Identity the Way You Want
Hi John,
Yesterday's new security innovation is today's gateway for hackers to cause cyberattacks. Having one complex password to secure your data worked in the past, but not now.
As threats evolve, so does your company's cybersecurity defense. Not only must it stop current attacks, but also prevent future ones.
In our new whitepaper, "Better Ways to Deal with New Security Threats", we takeaway that:
Cybercriminals are seeking new vulnerabilities to compromise sensitive data and get paid doing so.
Current cybersecurity threats will remain an issue for the next two years, and new threats do not remove the use of phishing or ransomware attacks.
New solutions that do more than detect threats will decrease the likeliness of being targeted.
We know passwordless authentication can stop a high proportion of security breaches caused by compromised user credentials. Replacing this 'easy-to-steal' credential with biometrics or MFA solutions will enhance security measures.
Are you prepared for the future of cybersecurity? Get in touch with us to talk about your organization's authentication strategy.
Sincerely,
The BIO-key Team”
Getting interesting is an improvement from sheer torture
biometric, hmmmm... now this is getting very interesting.... eom
Another filing
Form4 today
Jim Sullivan 10k shares-multiple buys 3.31 avg
Dan58, Thanks for the heads up... I missed those form 4’s. So, why is Mickey D. buying shares after 22 years?
CEO has bought twice, not once. Four times if you count the two times in June.
And not just the CEO:
https://www.sec.gov/Archives/edgar/data/1019034/000143774920024691/xslF345X03/rdgdoc.xml
Dan58, Interesting... Transaction Code “P” (Open market or private purchase of securities). Well, Mickey D. ponied up for once. Now, we just have to wonder .... why?
BIO-key Launches PortalGuard IDaaS (Identity-as-a-Service) Cloud Authentication Solution, Enabling Secure and Flexible Identity & Access Management
Delivering Greater Value, Security, & Scale to Customers & Partners
WALL, N.J., Nov. 30, 2020 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of identity and access management (IAM) solutions powered by biometrics, today announced the launch of PortalGuard IDaaS, bringing the power of its award-winning PortalGuard identity and access management (IAM) platform to the cloud as a fully-hosted, scalable and secure identity-as-a-service (IDaaS) offering. PortalGuard IDaaS is operational, having already processed millions of authentication transactions for customers.
PortalGuard IDaaS includes BIO-key’s NIST-certified device-or-server biometric authentication factors, along with fourteen other options for flexible authentication. PortalGuard IDaaS is already operational, having processed millions of authentication transactions for customers. As the demand for always-on cloud computing rises to an all-time high with the global shift to work-from-anywhere, PortalGuard IDaaS lets customers accelerate deployments, cut costs and simplify operations instead of managing an mission-critical IAM solution on-premise. BIO-key’s PortalGuard IDaaS helps organizations across all industries become secure “cloud first” businesses, while maintaining the highest levels of security through PortalGuard’s unmatched integration flexibility and support for a wide variety of authentication factor choices.
Work-from-anywhere software-as-a-service (SaaS) solutions allow public and private entities to provide secure access to applications for employees and customers operating outside of a company’s traditional security perimeter. Security vulnerabilities such as phishing, ransomware, account takeovers and handovers continue to challenge enterprises to secure user access in the increasingly precarious work-from-anywhere landscape. Security teams struggle with adapting the complexity of mainstream IAM solutions and authentication methods to a dynamic group of roving, on-premise and at-home workforces and customers. Many find mainstream one- or few-size-fits-all IDaaS multi-factor authentication (MFA) options, such as phone-based SMS, apps and USB tokens, as both costly to deploy and ineffective in truly identifying individuals gaining access to critical systems. Strategic use of biometric authentication provides greater controls and governance capabilities for these access scenarios, at significantly lower costs.
IDaaS is expected to experience strong growth. Gartner anticipates a 35 percent increase in global midsize and larger organizations using IAM capabilities delivered via SaaS to fulfill most of their identity needs, a prediction made prior to the COVID-19 driven shift to work-from-anywhere. Gartner also predicted growth for biometric authentication thanks to its lower deployment costs, better phishing resistance and superior user experience. BIO-key’s PortalGuard IDaaS is an efficient and proven means for customers to be ready for whatever challenges the future brings.
BIO-key’s PortalGuard IDaaS allows customers to select a deployment model that works with their security requirements and timelines. Regardless of the model chosen, PortalGuard supports nearly every cloud authentication federation standard, all major user directories, and a wide variety of authenticators, including BIO-key’s acclaimed biometrics platform.
“We believe enterprises should have choices to secure identity the way they want, including leveraging a SaaS model for simplified deployment and operation of their IAM solutions,” says Michael DePasquale, CEO of BIO-key International. “IAM technology needs to be flexible, available everywhere, and highly reliable, allowing customers to focus on their mission, while our PortalGuard IDaaS secures their access points. This launch demonstrates our continued investment in market-leading SaaS and biometric innovation to provide customers with greater security, value and flexibility when they need it the most.”
“For us, the value was in moving the portal out of our data center to reduce the impact of any downtime related to our data center (many of the links in our portal are to other Cloud-based services not hosted in our data center),” said David Ayersman, Vice President and Chief Information Officer, at New River Community and Technical College. “We’re expecting that the total cost of ownership offered by moving to PortalGuard IDaaS will eventually prove to be lower, since the burden of hosting and maintaining the solution is no longer on us. And with SaaS, we’re also expecting that as new features become available, we’ll be able to get them without delay.”
"As a long-time PortalGuard customer, our company is keen to consider a SaaS delivery model," said Phillip Serio, Manager of IT Security at Hershey Entertainment & Resorts Company. “We continually evaluate our application stack to determine if it makes sense to transition to a cloud-based solution. With a majority of our SSO (Single Sign-on) apps now being cloud-based, moving our PortalGuard deployment to this new SaaS offering aligns with current initiatives that improve availability while also removing the management overhead from our internal teams to maintain the current on-premise architecture.”
About BIO-key International, Inc. (www.bio-key.com)
BIO-key is revolutionizing authentication with biometric centric, multi-factor identity and access management (IAM) solutions, including its PortalGuard IAM solution, that provide convenient and secure access to devices, information, applications and high-value transactions. BIO-key’s proprietary software and hardware solutions, with industry leading biometric capabilities, enable large-scale on-premise and Identity-as-a-Service (IDaaS) solutions as well as customized enterprise and cloud solutions.
BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; our ability to execute and deliver on contracts in Africa; our ability to expand into Asia, Africa and other foreign markets; the duration and severity of the current coronavirus COVID-19 pandemic and its effect on our business operations, sales cycles, 3 personnel, and the geographic markets in which we operate; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption see "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2019 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, the Company undertakes no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise. Additionally, there may be other factors of which the Company is not currently aware that may affect matters discussed in forward-looking statements and may also cause actual results to differ materially from those discussed. In particular, the consequences of the coronavirus outbreak to economic conditions and the industry in general and the financial position and operating results of our company in particular have been material, are changing rapidly, and cannot be predicted.
Engage with BIO-key:
Facebook – Corporate: https://www.facebook.com/BIOkeyInternational/
LinkedIn – Corporate: https://www.linkedin.com/company/bio-key-international
Twitter – Corporate: @BIOkeyIntl
Twitter – Investors: @BIO_keyIR
StockTwits: BIO_keyIR
Investor & Media Contacts
William Jones & David Collins
Catalyst IR 212-924-9800
Well that's a start anyway.
Open market buy: 5000 @ $3.25 11/24/20
https://www.sec.gov/Archives/edgar/data/1019034/000143774920024387/xslF345X03/rdgdoc.xml
Today: More slide.
"Cap'n! We're takin' on water!".
Identity and Access Management Provider BIO-key Presents at Imperial Capital Virtual Security Investor Conference Wednesday, December 2nd
WALL, N.J., Nov. 25, 2020 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of identity and access management (IAM) solutions powered by biometrics, today announced that its Chairman & CEO Michael DePasquale will present at the 17th Annual Imperial Capital Security Investor Conference on Wednesday, December 2, 2020 at 12:30 pm ET. The Conference will connect approximately 70 public and private security-focused companies with 500 key investors and business leaders. For health and safety reasons, this year’s conference will take place virtually over two days December 2-3, 2020.
Now in its 17th year, Imperial Capital’s Security Investor Conference remains the security industry’s leading investor conference, bringing together a select group of companies to present their positioning and strategic growth plans to key investors and business leaders. This virtual gathering of presenting companies and executives with institutional and private equity investors provides an opportunity to learn about companies delivering the latest in compelling security solutions across global Consumer, Enterprise and Government markets.
About Imperial Capital, LLC (www.imperialcapital.com)
Imperial Capital is a full-service investment bank offering comprehensive suite of services, including sales and trading, capital markets and restructuring, research and investment banking advisory, to institutional investors and middle market companies.
About BIO-key International, Inc. (www.bio-key.com)
BIO-key is revolutionizing authentication with biometric centric, multi-factor identity and access management (IAM) solutions, including its PortalGuard IAM solution, that provide convenient and secure access to devices, information, applications and high-value transactions. BIO-key’s proprietary software and hardware solutions, with industry leading biometric capabilities, enable large-scale on-premise and Identity-as-a-Service (IDaaS) solutions as well as customized enterprise and cloud solutions.
Engage with BIO-key
Facebook – Corporate: BIO-key International
Twitter – Corporate: @BIOkeyIntl
Twitter – Investors: @BIO_keyIR
StockTwits: BIO_keyIR
Investor & Media Contacts
William Jones, David Collins
Catalyst IR
212-924-9800
bkyi@catalyst-ir.com
Any word from Management what they are doing today to increase shareholder value in this emergency situation of continued decline of pps?
Are they in a meeting formulating their SWOT strategy at this moment?
PR by noon to lift us 400% or more?
Hello?
Thats true, but I have 25 grandchildren who might enjoy it someday. I'm blessed that I don't need it!!
Watch "Turn Your Eyes Upon Jesus by Alan Jackson" on YouTube
And that's just to get even! No gain for 20 YEARS!!
Nope, exactly $17.35 per share for me HODL FOR 20 YRS
Probably just another pump!!
The usual crud this stock puts out.
This stock price would have to go to like over $30 or more (have not even tried to figure it out) a share for the longs to make a buck. Not in my life time!!
Self serving CEO and board members have made this company their bread and butter at the expedience of the share holders.
Lots of unexplained BS here. Like do you think Wong would have voted for a reverse split? He almost has to for it to pass.
Could be.... price seems to be dropping after initial excitement surrounding this announcement. Typical..... hard to trust the value of anything BKYI announces.
Identity and Access Management Provider BIO-key Partners with Prominic.NET to Provide Advanced, Flexible User Authentication Security for U.S. DoD Agency
WALL, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of identity and access management (IAM) solutions powered by biometrics, today announced that it has partnered with Prominic.NET, an owner and operator of data centers serving businesses running on HCL Digital Solutions (formerly IBM Collaboration) products, to deploy BIO-key's PortalGuard IAM solution to a U.S. DoD agency. PortalGuard will provide enhanced user access security to the agency’s enterprise applications and data via secure smart card authentication.
BIO-key implemented its PortalGuard IAM solution on the enterprise-grade HCL Domino-based environment to support application access requirements for the DoD agency’s mission-critical environment. PortalGuard is being used as a Security Assertion Markup Language (SAML) Identity Provider to provide Single Sign-On (SSO) capabilities for the load-balanced environment. PortalGuard is also being used to configure support for Personal Identity Verification (PIV) credential smart card authentication that enables access to application data. In addition, PortalGuard provided a split login experience where users without a PIV credential smart card could still login manually using traditional two-factor authentication methods, showcasing the solution's flexibility in supporting different user types and access conditions.
"We are proud and excited to be selected for this important DoD application environment," stated Mark Cochran, President of BIO-key - PortalGuard. "PortalGuard delivers a complete IAM solution for both on-premises and SaaS offerings that give customers the flexibility to choose based on their application security needs and Time to Value expectations. The combination of single-sign-on and multifactor authentication capabilities allows PortalGuard to provide a higher level of configurable security to protect our customer's critical systems and data."
About BIO-key International, Inc. (www.bio-key.com)
BIO-key is revolutionizing authentication with biometric solutions that enable convenient and secure access to devices, information, applications, and high-value transactions. BIO-key's software and hardware finger scanning solutions offer secure, user-friendly, and attractively-priced alternatives to passwords, PINs, tokens, and security cards, enabling enterprises and consumers to secure their networks and devices as well as their information in the cloud.
BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; our ability to execute and deliver on contracts in Africa; our ability to expand into Asia, Africa and other foreign markets; our ability to integrate the operations and personnel of PistolStar into our business; the duration and severity of the current coronavirus COVID-19 pandemic and its effect on our business operations, sales cycles, personnel, and the geographic markets in which we operate; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption see "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2019 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, the Company undertakes no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise. Additionally, there may be other factors of which the Company is not currently aware that may affect matters discussed in forward-looking statements and may also cause actual results to differ materially from those discussed. In particular, the consequences of the coronavirus outbreak to economic conditions and the industry in general and the financial position and operating results of our company in particular have been material, are changing rapidly, and cannot be predicted.
Facebook – Corporate:
Twitter – Corporate:
Twitter – Investors:
StockTwits: BIO-key International
@BIOkeyIntl
@BIO_keyIR
BIO_keyIR
Investor & Media Contacts
William Jones, David Collins
Catalyst IR
212-924-9800
bkyi@catalyst-ir.com
Lmao. This turd will go back under a buck. She heavy imo
That’s correct, the problem with reverse splits is that the stock tends to sell off aggressively after the split. So if you take the last two splits the stock sold off probably 90% plus.
Today’s price of $2.90 is lower than the clothes yesterday and in the coming days and weeks, odds are it will sink even lower.BIO-key management wants to get the stock price up, they need to do with the old fashion way, they need to sell stuff taken revenue, get paid for it and show a profit.
That is something BIO-key management has not been able to do for the last 20 years. A reverse split doesn’t help that, it actually makes things even worse because those who don’t know that many shares after the split have a tendency to just knock them and get out
For me to hold a lousy 28,000 shares the way I invest is almost a worthless endeavor. I would probably also add that I probably own more shares then all insiders combined with the exception of maybe Calvin Wong, of course that’s if Wong even owns any shares now.
Thanks for the information but I do understand how reverse splits work.
Problem with reverse splits is that they tend to continue going down after the split. Effective price of BIO-key stock yesterday would’ve been $3.12 I believe if you adjusted for the split. Of course by today’s numbers were down to $2.93 so we did lose ground.
What’s more important to understand is that this is now the third reverse split that BIO-key has done in probably the last two years.
The first split was the one for two reverse and the next split was a one for 12 split now add another one for eight reverse split and the additional lost and share price today. Not pretty.
I understand how the share account works but I would ask you to keep in mind something. Are used to hold 5.4 million shares of the stock. Now after all of the reverse splits I am 28,000 shares.
I have told management several times not to do the reverse split and drop the NASDAQ listing. It has done nothing for us and unfortunately management does business with a bunch of crooks that destroy shareholder value anyway. They profit handsomely off of BIO-key but screw the longtime shareholders and investors in the process.
Keep an eye on the short interest numbers that come out in the next couple of weeks. Right now I believe there’s about a 2.9% short interest. If you see a spike up, you’ll know that our friends at Maxum And the other lowlifes that we do business with will most likely short the hell out of this let it collapse and then cover
towelguy, jonQ is equating the price per share had the 3 reverse splits not happened. jonQ’s math is correct.
think you got it wrong reverse split is share price increases and share amount goes down. basicly you have same value of stock just divide your shares by 8 and increase stock price by 8.
So if I have calculated this correctly, you need to take the BIO-key share price and divided by 192 and that will give you the equivalent share price backing out the reverse splits.
That would now give us an equivalent share price of .015 cents
All the stock is worth today is a penny and a half.
Awesome, Bonuses for everyone
500,000 shares traded this morning in the first 90 minutes of trading. Do we now multiply that times eight for what our real trading volume is. If so that means we traded The equivalent of roughly 4,000,000 shares in the first 90 minutes
Another 6% loss and share value today, who could’ve seen that one coming?
Let’s do another reverse split next month.
BIO-key’s short interest,
BIO-key’s short interest is 2.27% of the outstanding. Wait till you see what it’s like next week when I find friends that maxim short the crap out of this again. I think we can look forward to a 50% short interest as they let the price collapse again.
For those of you that are looking for something positive out of this reverse split, may I suggest you look at the BIO-key stats.
If you check them right now, we are trading at a 52 week high and by a significant margin. That should make you feel good.
Of course Monday morning when the statistics get re-calculated will be at a 20 year low. But at least you’ll get to feel good for the weekend.
Reverse split worked like a charm. I wonder how big of a trophy we get when we win the race to the bottom?
I have to admit, I have got incredible trading skills.
I managed to go from 5.4 million shares of BIO-key to 28,000 shares of BIO-key without selling one single share.
I challenge you to find someone else that has that kind of training skills.
I told management the same thing, dump the NASDAQ listing. It’s irrelevant and does nothing for us.
For since we went on the NASDAQ, the share price has done nothing but go down. Last to reverse splits were devastating to the company.
You know what’s the definition of insanity is,
Doing the same over and over again and expecting a better result. BIO-key is done to reverse splits in the last year or so and both were failures. Why in the world would they think another one would be any different?
They should have cut cut 2/3 of the workforce and then we’d be in at least better condition. It’s not like they actually sell anything anyway.
It's Mikes Birthday today. Lets all wish him a big Happy day, he got his split again and again. He and his cronies to get out. They pretty much sliced and sucked every bit Bio-Had.
It’s the same question I had to ask. Who the hell would do this one again. It’s not like we haven’t seen it twice before. Reverse splits do not work, never have and never will.
I voted 250,000 shares against. I guess I just don’t understand BIO-key. I guess their mission is trying to win the race to the bottom. It looks like they’re going to do it.
What they really need to do is reverse split the employees,They should fire two employees for every three they have.
Great point! Exactly what I was thinking.
I sold for a big loss its a pitty this stock was hit with short sellers.
Honestly it woukd of bean a better move to go to otcqx and you get rid of shorting and move up when you grow enough
Enablers who want to keep this farce going as long as possible. Why would a reverse split even be necessary if their reported Africa deal was real?
Who in their right mind would vote for another reverse split????
Time to sell and wright it off!!
Thanks to another reverse split at 1 for 8. Incompetency thrives at BKYI.
Good going BIO-key management, and all new 52-week low.
My prediction is that after the split it will sink even lower.
If anyone hears what the results were on the election, Please post.
DISCLAIMER
Nothing in the contents transmitted on this board should be construed as an investment advisory, nor should it be used to make investment decisions. There is no express or implied solicitation to buy or sell securities. The author(s) may have positions in the stocks or financial relationships with the company or companies discussed and may trade in the stocks mentioned. Readers are advised to conduct their own due diligence prior to considering buying or selling any stock. All information should be considered for information purposes only. No stock exchange has approved or disapproved of the information here.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |